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It is well established that storage of cells in a liquid
milieu leads to degradation processes, and to eventual
loss of cell viability. At the same time, intracellular ice
is lethal for the majority of cells [43]. Thus, the only
stage in which cells can be stabilized would be a solid-
like phase in which intracellular ice crystals are not
formed, or have not grown to the “critical lethal size”.
Such a vitreous (“glassy”) state has elevated viscosity
(up to 1014 Pa×sec), so processes of chemical and
physical degradation are essentially stopped for the
duration of the experiments or storage. There are five
basic ways to achieve vitrification; all lead to drastic
decreases of water activity:
– Equilibrium (slow) freezing-out of the bulk of
water to ice form, followed by storage at extremely
low temperatures, usually –196°C, recently –130°C
to –80°C. This is the ‘mainstream’ conventional
cryopreservation, which in the majority of cases
requires the use of permeable and impermeable
cryoprotective agents (CPAs).
– Slow freezing to moderately low (around –40°C)
temperatures, sublimation of the bulk of ice at very
high vacuum, and secondary drying of the “cake” at
elevated (up to 30°C) temperatures.  This method
called lyophilization is widely used in food production,
microbiology and in the pharmaceutical industry, but
has had so far very limited applications in the
preservation of animal cells and higher plants.
– Ice-free vitrification of cell suspensions, tissues,
and organs at very low temperatures and moderate to
high rates of freezing. This method requires the use of
a high concentration of vitrificants (historically but
erroneously referred to as “CPAs” in analogy with
slow freezing), which elevates the viscosity of the
milieu and prevents the ice formation during cooling
and devitrification during warming. We refer to this
method as “vitrification proper”, and it has had limited
but notable success in preserving animal oocytes,
embryos, and organs, as well as plant specimens.
– Ice-free vitrification of a bulk solution by very
fast (abrupt) plunging into a cooling agent such as liquid
nitrogen. The extremely high rate of cooling (105 to
106 °C/min) and practically instant warming prevents
ice formation in small samples, and does not require
the use of potentially toxic high concentrations of CPAs,
so we refer to this as “CPAs-free vitrification”.
– “High temperature” vitrification of a highly
dehydrated sample and stabilization by air/vacuum
drying at temperatures >0°C.
In this paper, we discuss the mechanisms of
vitrification that are common to all these methods, as
well as specific aspects, advantages, and pitfalls of
each one. The emphasis is put on stabilization of
embryonic and adult stem cell cells by means of low
and high temperature vitrification.
1. Vitrification of Cells: Historical Background
The idea of using freezing and drying to preserve
food and other perishable materials goes back
thousands of years to prehistoric times. However, long-
term preservation of living objects, and particularly of
cells of animals such as vertebrates, mollusks and
insects, is a novel approach. A truly pioneering work
on cryopreservation was performed by an Italian priest
and scientist Lazzaro Spallanzani in in 1776 when he
“froze” stallion sperm in snow, noting the recovery of
sperm motility upon warming (published in [59]). Later,
in  the 19th and the first half of the 20th century scientists
elucidated some aspects of the mechanisms of cold
adaptation of living matter, particularly, those used by
plants and fungi. The most important initial contributions
in this area were made by the Father Luyet, who has
been rightfully called the founder of the science of
Cryobiology. From the outset, he recognized that ice
damage must be avoided, and that vitrification could
be a method for preservation of cell viability [40] In
1938 Luyet and Hodapp achieved survival of frog
spermatozoa vitrified by plunging into liquid nitrogen
[39] and later several Western European groups
reported their experiences with attempts at cryo-
preservation of fowl [56], human [23, 28, 48] and rabbit
[23] spermatozoa with varying success. These efforts
did not receive the recognition they deserved, hindered
by the variability of the reported results and by the
Second World War as well.
While the contributions of Father Luyet have been
well recognized, the research of another pioneer in
the field has not been widely known within the Western
scientific community. Emmanuil Yakovlevich Graev-
sky. His work in 1946-1948 was not only confirmation
of the Luyet’s observations, but Graevsky and
colleagues introduced a lot of novel techniques and
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ideas, both regarding mechanisms of vitrification and
devitrification, and practical methods of vitrification.
Particularly, pointed out the possibility of using
vitrification as a method of long-term stabilization and
preservation of cells [18, 19], and in [17, 19] he reported
that following Luyet’s technique, he successfully frozen
frog sperm with even better than the original Luyet’s
results. Moreover, he was one of the first to use a
small loop to effectively vitrify suspensions of bacteria
[20]. Only in the past few years this method (now
called “cryo-loop”) has been applied to the vitrification
of mammalian cells, particularly to the cryoprotectant–
free vitrification of human spermatozoa, which we will
discuss in more details below.
The approach to vitrification developed by Luyet
and later improved by Graevsky and by Hoagland and
Pincus (they also used cryo-loop in [23]) was based
on the application of relatively fast cooling rates.  Yet,
recovery of the sample viability was low and very
variable mostly because, as the authors recognized,
sufficiently rapid cooling and warming, which must be
very high for low concentrations of CPA’s, were not
achievable. One of the reasons was that very low
temperature cooling agents such as liquid nitrogen and
liquid oxygen were not used in their research. As a
result, the mainstream of cryobiology turned to
preservation methods based on slow freezing. This
approach was facilitated by the discovery of the
protective properties of glycerol on human and animal
sperm when spermatozoa were frozen to extremely
low temperature, made independently by Igor Smirnov
in the USSR [57] and by Alan Parkes and colleagues
in the UK [49, 58]. (Parkes also deserves mention for
coining the term cryobiology, the study of “frosty
life”). Note that the cryoprotective qualities of glycerol
and other low molecular weight, mostly non-electrolytic
substances had been described before. For example,
Bernshtein and Petropavlovski in 1937 used 0.5 to 3.0
Mol/L glycerol and other electrolytes for freezing of
bull, ram, stallion, boar and rabbit spermatozoa to a
temperature of –21°C; they reported to have obtained
the best results at 0.5-2 Mol/L glycerol [8]. However,
only after development of stable long term cryo-
preservation at very low temperatures (–196°C and
lower) initiated by Smirnov’s and by Parkes’s groups,
the true era of practical applications of cryobiology,
particularly for animal breeding, began in the West and
in the Soviet Union. For the next four decades, the
slow-freeze method dominated the field of cryo-
preservation, and it still remains the basis of the majority
of cryobiological techniques in use in production
facilities and research laboratories. Progressively more
sophisticated understanding of the mechanisms
underlying cell damage during the slow to moderate
rate of freezing as well as methods to prevent it were
contributed first of all by Mazur [42, 43], and also by
Lovelock [38] Meryman [46], and by many others.
While ‘conventional’ slow freezing had given
satisfactory results for many suspended cells, such as
blood, sperm, and embryos, issues of ice formation and
non-homogeneity of samples’ thermal profiles made
slow freezing and thawing a formidable task for tissues
and organ. The breakthrough came when Fahy and
colleagues vitrified an entire organ – a kidney [13].
The presence of high concentrations of vitrificants,
particularly glycerol, allowed an ice-free bulk glassy
state to be achieved both inside the organ (it was done
by perfusion) and in the external milieu. By tradition,
glycerol and other vitrificants were still called
“cryoprotective agents” (CPAs) as for slow freezing,
probably because the same chemicals were used for
both applications. However, one has to remember that
for ice-free vitrification, they play a completely
different role (as glass-formers) than for slow freezing
(as osmotic buffers and “water holders”).
Vitrification eliminated many of the problems related
to the slow freezing of liquid water to an ice phase,
particularly extensive rehydration and osmotic damage,
the increased ionic strength of concentrated eutectic
solutions, and shifts in pH. However, vitrification in
high concentrations of vitrificants introduced its own
set of problems.  Notable among them were osmotic
damage during addition and removal of vitrificants,
CPA toxicity, mechanical cracking of glasses, and
devitrification due to inadvertent thermal cycling during
storage.
Nevertheless, practical applications of vitrification
as a method continued to grow, specifically after Rall
and Fahy reported the successful vitrification of mouse
embryos in 1985 [52]. However, more widespread  use
of vitrification was slowed by the inherent pitfalls of
high-CPA methods, and also by the lack of under-
standing of the mechanisms of vitrification and
devitrification by most practitioners of the craft. By
the 1980s, the fundamental work of Luyet had been
largely forgotten, and the theoretical and practical
contributions of Graevsky—published in Russian—had
never achieved the recognition they deserved.
Unfortunately, the pioneering work of the cryobiologists
of the 1930s, 1940s, and 1950s is still underappreciated
today.
In the 1990s, vitrification was applied to new areas
such as oocytes and ovarian tissues. However, the
sensitivity of germ and blood cells to cryoprotective
agents made this approach prohibitive, despite the fact
that vitrification can be simple, fast, and cheap. Instead,
practitioners, farmers, and blood bankers committed
to the slow-freezing route, with its attendant need for
expensive, programmable cryo-equipment and skilled
technical personnel. Vitrification was a resounding
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success with non-mammalian species, particularly
insect embryos and plant species [44, 51, 60, 63].
Vitrification protocols have been developed for
cryopreservation of marine invertebrates [12], turbot
[54], and zebrafish [65] embryos. Moreover, the recent
discovery of the high ice-nucleation temperature of
zebrafish embryos suggests that slow freezing is not a
suitable option for zebrafish embryos, so vitrification
seems to be the method of choice [22]. Greg Fahy,
one of the pioneers in the use of vitrification to preserve
entire organs, and his collaborator Brian Wowk recently
reported progress in custom-synthesizing vitrificants,
and tailoring cooling and warming profiles to fit their
ice-blocking qualities [14].
The advances in methodology recounted so far
improved cell survival without much reduction in the
dependence on high concentrations of cryoprotective
agents. A new breakthrough came in 2002 when
Nawroth et al [47] vitrified human sperm without any
conventional CPAs by using a simply constructed
cryonic copper loop to present the sperm in a film, or a
pellicle.  The key was very rapid cooling up to hundred
of thousands °C/min [24]. They had, essentially,
rediscovered the method used by Luyet and Graevsky
more than a half century ago. It has developed that
the rate of warming is even more important to survival
under these conditions than is cooling.   Thus, it appears
that intracellular vitrification can be achieved at
relatively low rates of cooling without the use of CPAs
and preliminary dehydration. This is presumably
facilitated by the low All of the methods mentioned
above rely on storage at an ultralow temperature (about
–196°C in liquid nitrogen) ice-free vilification. However,
independently, vitrification has long been used in food
preservation and pharmaceutical industries. Here
vitrification is followed b y sublimation of ice, with the
objective being the achievement of long shelf-life
stability. A lot of important knowledge, such as the
crucial role of the glass transition temperature (Tg),
stability, shelf-life, plasticizers vs. glass-formers, all
have come to cell stabilization from that area.  High
temperature vitrification is now an interdisciplinary field,
where collaboration of specialists in thermodynamics,
solid matter, physical chemistry, biophysics, cell biology,
and medicine has become a matter of routines. It is
especially true for lyophilization and high-temperature
(above 0°C) drying (vacuum or air- likewise) of
mammalian cells. However, despite the claims of
success in lyophilizing erythrocytes [7, 15, 35], platelets
[53, 61, 64], or even spermatozoa [9, 36, 62], the clinical
or commercial applications of high temperature
stabilization and long term storage of mammalian cell
remain an elusive goal.
The most novel approach to achieve glassy state in
mammalian cells at high, even ambient temperature is
vacuum or air drying at temperatures above 0°C. This
is an emerging area of animal cell stabilization, in which
our group has been one of the pioneers [16, 21, 31, 33,
50], however, still the data in literature are scarce [41].
We will discuss this approach and our recent results in
a separate Chapter in more details.
Let us now give a brief description of basic
approaches for vitrification, its achievements, and
future directions.
2. Conventional (Slow) Freezing for
Cryopreservation
Traditionally, in the cryopreservation community,
slow freezing is not associated with vitrification and is
often mentioned as an alternative approach. However,
in fact, during growth of crystals, the bulk of water is
freezing out to the ice, and remaining liquid part
becomes more and more concentrated. The cell cannot
survive with big ice crystals inside, so intracellular ice
formation in the majority of cases kills the cells [43].
However, if freezing is performed slowly enough (the
critical speed depends on the surface/volume ratio and
water membrane permeability as function of
temperature), than cells are loosing water practically
in equilibrium with the extracellular compartment. The
quantitative theory of the process was introduced by
Peter Mazur [42], and developed further by other
investigators. Aside from technicalities in the
description processes, the major aspect remains the
same: viable cells will be those ones, which are located
in a solidified space between the ice crystals, and their
intracellular compartments are also free of ice. Such
solid state that assures survival of cell at this extremely
low temperature can be only the glassy state. As we
see, even for conventional slow (equilibrium) freezing
vitrification as the final phase of the freezing process
is essential for Despite that this method is widely used
and has drawn a lot of attention, there are many
interesting questions remaining, particularly, the central
dogma that “intracellular ice always kills” recently
underwent scrutiny by Dr. Locksley McGann and
colleagues [1-2]. Moreover, even Peter Mazur, the
author of this postulate, has recently questioned its
absolute applicability to all scenarios [45].
Even though conventional equilibrium freezing has
been successfully used for many type of cells, and
some tissues, some cell types, such as human embryonic
stem cells (hESC), are very sensitive to use of it. As
we showed recently, slow freezing with 10% DMSO,
which has been widely used for cryopreservation of
many cell lines, including mouse ESC, led to almost
complete depletion of production of a crucial marker
of pluripotency, Oct-4.  The native protein, under the
control of the wild-type promoter, was conjugated with
green fluorescent protein (the data were briefly
reported in [30-32, 34] and will be published in details
elsewhere). That means that even though over 50%
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of the cells survived cryopreservation, the over-
whelming majority of them would uncontrollably
differentiate or eventually die due to senescence and
apoptotic transformation, so only 10% of original stem
cell population regained its ‘stemness’ (pluripotency)
after conventional freezing (Fig. 1). Taking to the
account that pace of dividing hESC much slower than
“standard” cell lines (4-6 days vs. 18 to 48 hours for
cells like primary fibroblasts or HeLa), the problem of
optimization of cryopreservation techniques is a very
challenging and important problem.
So, despite definite successes, the slow equilibrium
process has its own limitations and therefore new
methods have to be developed.
3. “Conventional” Vitrification with High
Concentrations of CPA and Moderately Fast
Freezing and Warming Rate (“Fahy’s
approach”)
As mentioned above, there are two ways of
achieving ice-free vitrification upon cooling and
avoiding devitrification during warming. The first
method was proposed and extensively investigated by
Luyet and his colleagues in the 1930-50s and by
Graevsky in 1946-48. They stated that if a specimen
was cooled and warmed very quickly then ice would
not be formed so vitrification of the bulk solution would
occur. However, as Fahy pointed out [13], this
approach would require special small volume
techniques that were not widely available in Luyet’s
and Graevsky’s time. As a result, this direction was
essentially abandoned, and investigators focused on
another approach, in which relatively low (<200 K/min)
rates of cooling and warming can be used but requiring
very high (about 60% (w/w) cryoprotectant concentra-
tions. This method of vitrification was used by Fahy
et al.  [13] to successfully preserve living systems.
They were the first to report the vitrification of a whole
organ (kidney) using a combination of high concentra-
tions of PCPs and high pressure (up to 1000 atm). For
the preservation of large organs and tissues, this
approach can be considered as the matter of choice
due to the inherent difficulty in achieving homogeneous
distribution of freezing and warming rate, which is
crucial for “classical” cryobiological protocols. Report
of the vitrification of mammalian embryos was soon
to follow [52], and the method became a popular tool
for the cryopreservation of large single cells, and cell
clusters such as oocytes and embryos. However, this
did not imply that the original approach proposed by
Luyet for suspended small single cells was impossible
in principal. The problem was simply that procedures
for ultra-rapid cooling and thawing had not been
sufficiently developed yet. The recently introduced
carrier systems such as open pulled straws (OPS) and
cryo-loops have changed the situation.
4. Cryoprotectant-Free Vitrification by Very
Fast Freezing and Instant Thawing (“Luyet-
Graevsky’s Approach”)
The main process involved in crystallization and
conditions for ice-free can be summarized in the
supplemented phase diagram proposed by Greg Fahy
[13]. The larger difference between homogenous ice
crystallization curve Th and the glass transition curve
Tg, the higher probability that crystallization of the
solution will occur during freezing. That area called
Zone I and Fahy and colleagues considered probability
of vitrification at the rate of freezing they used (up to
thousands °C/min) very low, and probability of ice
crystallization would be almost 100%. As the
concentration of CPA (vitrificant) increases, the
temperature of homogeneous ice crystallization drops,
while Tg rises. At the point when they Th meets Tg,
Zone III begins, and there is a probability of achieving
vitrification during appropriately fast freezing.
However, devitrification curve Td indicates that there
would be a higher possibility of devitrification during
warming. Td drastically increases with higher % of
CPA (vitrificant) due to dramatic rise of viscosity, and
when Td meets the non-homogeneous equilibrium
crystallization (melting) curve Tm, Zone IV begins at
the point, from which crystallization and devitrification
never occur at any reasonable rate cooling and
warming. Note, however, that for “conventional”
vitrificants such as glycerol, such concentration is in
the range 65-70%, which is extremely high, and
basically none of known mammalian cells would
withstand such enormous (tens of Osm) osmotic
pressure. Thus, vitrification should be performed in a
kinetic way, playing with concentration of the vitrificant
and rate of freezing and warming. Fahy and colleagues
defined that zone when practical vitrification is
achievable, from 45% of CPA, marking this as Zone II.
The critical speed of cooling and warming, however,
is reverse to the concentration of the CPA, and vise
versa: as higher speed of rate of cooling/warming, as
lower concentration of CPA is needed, so basically
the border between ‘non-achievable’ and ‘achievable’
vitrification (Zones I and II) is arbitrary. It means
that if the speed of cooling and warming are high
enough, then concentration of the glass-formers can
be very low (the dashed line is a new border between
Zone 1 and Zone II). That has been the main direction
for the last decade in vitrification cryobiology,
particularly for reproductive cells. Several types of
devices, such as open-pulled straws, microscopic grids,
and cryoloops were explored to increase speed of
cooling and thawing and, thus, to decrease the CPA
concentrations to values of 25-30%. While it has been
working well for oocytes and embryos, small cells like
sperm and erythrocytes have been proven to be
practically intolerant even to such “moderate”
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Fig. 1. Human Embryonic Stem Cells (hESC): Loss of a marker of pluripotency Oct-4 (transcription factor conjugated with
Green Fluorescent Protein) after “standard” slow freezing and the use of 10% DMSO. Figs A, B, C, D: two color FACS
analysis channel 1 is GFP (indicates presence of Oct-4); channel 2- PI, a stain for viability. Figs E, F, G, H: fluorescent
microphotography of the same samples of the cells using green filter. Figs A, E: fresh cells (unfrozen control); 65.7% of the
cells are both GFP-positive and PI-negative represent non-differentiated viable cells, while 33.5% are differentiated (GFP-
negative) but viable cells. Figs B, F: hESC in 3 days after thawing. The four distinctive regions can be determined: 36.5%
of the population are viable but differentiated cells, 48.6% are unviable differentiated cells (probably, due to apoptotic
pathway), 3.43% of cell are PI-positive, but they still have a sizable of Oct-4 (probably, senescent cells), and only 10.1% of
the cells are viable non-differentiated, this pool is the subpopulation, which presents valid hESC. Figs C, G: hESC in 7 days
after thawing: amount of non-differentiated viable SC doubled due to division; substantial number of the differentiated
non-viable cells from Day 3 have died out, while some viable non-differentiated on day 3 cells are gone to the differentia-
tion pathway. Amount of senescent cells is negligible. Figs D, H: hESC in 14 days after thawing. Majority of the senescent
cells have died out, and doubling of non-differentiated cells eventually replaced the pool of differentiated and presumably
non-proliferating cells. This diagram and the general look under fluorescent microscope are almost identical to fresh
control (cf. A vs. D, and E vs. H respectively). The data were briefly reported in [29-32] and will be published in details
elsewhere.
G HE F
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concentrations of CPA (e.g., 30% of most widely used
CPAs as glycerol, ethyleneglycol and propyleneglycol
equals to 15-20 holds of the isotonic value). However,
a major breakthrough came in 2001, when a group
from Germany managed to successfully vitrify sperm
without any conventional cryoprotectants when it was
cooled and frozen in very thin films (pellicles) in copper
cryoloops [47]. They basically rediscovered the original
Luyet-Graevsky approach, but with all new knowledge
that had been accumulated since the pioneering works
in 1939-1948. We then have been engaged in
collaboration with this group, and recently published
several joint papers [24-27], in which we suggested
that the extremely high rate of cooling (several hundreds
of thousands °C/min) and almost instant warming by
dissolving in a warm media made vitrification during
freezing without de-vitrification during re-warming
practically feasible. Taking into the account that the
culture medium contained proteins (serum albumin),
and the internal cellular milieu is abundant in high glass
transition temperature components such as proteins,
polysaccharides and nucleic, the vitrification can be
achieved at very low concentrations of non-osmotically
active glass formers, so no potentially toxic CPAs are
needed.
5. Vitrification by Ice Sublimation at T<0°C
with Consequent Secondary Drying at Higher
Temperatures (Freeze-Drying or Lyophilization)
Another direction, in which the processes of
vitrification are involved is freeze-drying or lyophiliza-
tion.  The latter term is sometimes mistakenly applied
to ice-free high temperature vacuum drying as well.
While this method of preservation of perishable items
has became a method of choice in the food and
pharmaceutical industry long ago, success in
preservation of mammalian cells has been marginal.
As there are several presentations at this Meeting
regarding lyophilization, we will skip this topic. We would
like to emphasize, however, that the main reason why
engineers and production companies have chosen
freezing-sublimation at high vacuum is the fact that at
low water activity the sample becomes very viscous,
and that makes evaporation of the bulk volumes of
liquid practically unfeasible. In contrast, creation of
the “lyophilized” sublimation cake and subsequent
further rehydration during secondary drying facilitates
the process.
However, it still takes days to complete freeze-
drying. At the same time, if the surface/ratio of the
sample can be increased drastically, such during
foaming, spray drying, or drying in thin films and
monolayers, it will make high temperature drying
practically feasible.
6. Vacuum and Air Drying at Temperatures
Above 0°C: Application to Blood, Stem, and
Adherent Cells
As early as in 1938, Lepeshinskaya [37] observed
that bacteria that were left in a foam-like solidified
environment for many days retained high viability after
rehydration (she called it “moisturisation”). Later in
the nineteen-fifties and -sixties, Annear [3-6] dried
some bacteria in a foam-like solid matrix, which he
obtained by elevating temperature of the liquid (boiling).
Boiling occurs when the vapor pressure on the surface
of liquid exceeds the ambient pressure, so one way to
achieve boiling and subsequent foam-like structure is
to decrease the ambient pressure by applying moderate
vacuum. For a long time, specialists working in
lyophilization had tried to avoid foaming as a non-
controllable process which led to lower-quality
cakesRecently, this method, which has a number of
advantages over lyophilization, particularly in the speed
of drying and independence of time of drying from the
volume of the sample (scalability), has drawn the
attention of several groups, particularly Bruce Roser
in UK and Viktor Bronshtein in USA [10, 11, 55]. This
method has the potential to be a good alternative to
lyophilization (see Fig. 2).  In the future, it may be
successfully applied to the stabilization of suspensions
of mammalian cells, such as platelets, erythrocytes,
and B-cells (oft-used for biosensors).
Yet another approach is to dry cells in monolayers,
which is a natural fit for undisturbed adherent cells.
Recently, we were able to dry human fibroblasts (a
close biophysical analog to mesenchymal stem cells)
Fig. 2. High temperature stabilization- vitrification by dry-
ing: foamed mammalian nucleated cells. Hematopoietic stem
cells vitrified by foam formation and subsequent drying at
37°C to 40°C (final product is shown in Fig. A). The foam
can be stable for practically infinite time. Viability of cells
(preliminary, non-optimized protocols) after 2 years of keep-
ing in a fridge ad 4°C was more than 20% (staining with
Trypan blue is shown on Fig. B). Lyophilization killed all
the cells so all cells were stained after rehydration (Fig. C).
A B
C
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to water content as low as 0.47 g water /g dry weight
(for comparison the water content of intact fibroblasts
is in rang 5-6 g water /g dry weight).  For comparison,
the water content of fibroblasts in their native state is
X.X g water/g dry weight.  The cells maintained their
viability when stored at room temperature for up to 3
weeks (manuscript in preparation). Similar success on
vacuum or air-flow drying of nucleated cells have been
reported by other groups as well. However, to insure
high Tg of the dried sample, and therefore, long term
high temperature stability, the final water content should
be in the range 0.30 – 0.05 g/g dry weight.  At this
writing, no researchers are known to have achieved
this high level of desiccation without causing irreparable
damage to cells.  The next few years should see further
advances in this area that are as significant as those
that are discussed in this review (Fig. 3).
Many materials reviewed in this paper were obtained
in collaboration with our colleagues, and it is our great
pleasure to name Fred Levine (UCSD Cancer center), Min
(David) Kim (UCSD, The Burnham Institute), Vladimir and
Evgenia Isachenko (Bonn University, Germany), Iskren
Puhlev (UCSD Burn Center), Victor Bronshtein and Nadia
Katkova (UPT, Inc), Stephanie Oppenheimer (Osiris
Therapeutics, Inc), Marc Mercola, Maria Barcova, Alexey
Terskikh, and Ruchi Bajpai (The Burnham Institute),
Natalia Karpova (NIIH&BT, St. Petersburg, Russia), and
many others.
Fig. 3. Progress in drying of nucleated mammalian cells
achieved by our Laboratory in 2002-2004. The data were
briefly reported [29-33] and will be published in details else-
where:  – viability >50%;  – viability >20%/.
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